GSK adds jobs, capabilities to Canadian plant; Abbott's patent victory over J&J to stand;

@FiercePharma: Laid-off Pfizer reps join OT lawsuit. News | Follow @FiercePharma

> GlaxoSmithKline is investing more than $30 million to add dermatology product manufacturing capabilities and create 70 jobs at a Canadian plant. Article

> Abbott Laboratories' victory in overturning a $1.67 billion patent-infringement verdict won by Johnson & Johnson will stand, a U.S. appeals court said yesterday. Report

> British Prime Minister David Cameron announced major revisions to his planned changes for the state-run health service after his original blueprint drew criticism from doctors and members of his own coalition government, who called it a partial privatization of the system. Item

> Swiss Stock Exchange officials are investigating an unusual jump in the shares in Swiss medical device maker Synthes before its takeover by Johnson & Johnson, the Wall Street Journal said. Item

> Watson Pharmaceuticals confirmed it is applying for approval to market a generic version of Novartis' Pataday eye drops after the brand's owners filed a lawsuit to prevent its commercialization. Report

> Injectables maker APP Pharmaceuticals has expanded its Grand Island, NY, manufacturing facility by 13,000 square feet with a $38 million investment. Story

> GlaxoSmithKline purchased for cancellation 1 million of its own shares, with the highest price paid at 1295 pence per share. News

> Shareholders of Detroit-based Caraco Pharmaceutical Laboratories, majority-owned by Sun Pharmaceuticals, voted to become a private company. Story

> ProStrakan has launched its cancer pain drug Abstral in Canada, where it will be sold by its Canadian partner Paladin Labs. Article

Biotech News

@FierceBiotech: Cancer immunotherapies in vogue as specialists seek a "cure." Story | Follow @FierceBiotech

@JohnCFierce: NIH is handing out $200M to five institutions for translational med work. Item | Follow @JohnCFierce

> NIH fast tracks $720M for new drug discovery center. Article

> Sanofi forges Boston R&D Hub in scramble to absorb Genzyme. News

> Lundbeck nails PhIII for drug to curb alcohol dependence. Story

Drug Delivery News

> Pfizer, pSivida deal is about big market in patient compliance. Piece

> New delivery system gives Parkinson's patients better quality of life. Article

> Mist inhaler to treat lung disease may not be safe. Report

> UK company looks to move from nutraceuticals to pharmaceuticals. Story

> Nanoparticle delivery into inner ear may help hearing loss. Article

> Singapore scientists design hydrogels that react to pH, temperature. Item

Medical Device News

> Covidien to shake up management structure. News

> Cordis to rein in stent development, cut jobs. Item

> QIAGEN looks to buy Ipsogen. Report

> CerebralRx's FitNes system launched in Europe. Article

> Secant to work with Solvant on biomedical implants. Story

> Spinal Modulation snags $30M in Series D. Report

And Finally... It's all about the dopamine, says Dr. Nora Volkow, neuroscientist in charge of the National Institute on Drug Abuse. Story